No Comments

Travel update for tourists visiting Costa Rica

Travel Update

Costa Rica continues increasing the countries from which it will welcome foreign tourists.

Tourists wishing to visit Costa Rica via a flight must comply with these requirements:

  • Complete the online “Health Pass” epidemiological form: https://salud.go.cr.
  • Show proof of a negative RT-PCR test for the coronavirus. The sample for the test must have been taken no more than 72 hours before departure. For a multi-flight itinerary, the departure time of the first flight is used.
  • Obtain travel insurance. This can be either a pre-approved Costa Rican policy from INS or Sagicor, or an international policy that covers COVID-19 medical expenses of at least $50,000 and $2,000 for lodging. Tourists with homes/property in Costa Rica can contact seguros@ict.go.cr and request an exception to the lodging insurance portion.

Tourists must have remained in an authorized country for at least 14 days before travel.

Authorized countries for Costa Rica tourism:

  • UNITED STATES: Connecticut, Maine, Maryland, New Hampshire, New Jersey, New York, Vermont, Virginia, Washington, D.C., Arizona, Colorado, Massachusetts, Michigan, New Mexico, Oregon, Pennsylvania, Rhode Island, Wyoming California and Ohio.
    • As of Oct. 15: Residents of Florida, Georgia and Texas.
    • As of Nov 01: All U.S. citizens and residents.
  • CANADA: All citizens and residents.
  • MEXICO: All citizens and residents.
  • THE EUROPEAN UNION SCHENGEN ZONE: All citizens and residents.
  • UNITED KINGDOM: All citizens and residents.
  • CENTRAL AMERICA (including PANAMA): All citizens and residents as of Oct. 15.
  • SOUTH AMERICA: Citizens and residents of Uruguay.
  • THE CARIBBEAN: Citizens and residents of Jamaica.
  • ASIA: Citizens and residents of Japan, South Korea, Thailand, Singapore, and the People’s Republic of China.
  • OCEANIA: Citizens and residents of Australia and New Zealand.

Feel free to contact us or your embassy for further details.

Source: tico times.net

Comments (0)